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ABSTRACT Arboviruses are pathogens of humans and animals. A better under-
standing of the interactions between these pathogens and the arthropod vectors,
such as mosquitoes, that transmit them is necessary to develop novel control mea-
sures. A major antiviral pathway in the mosquito vector is the exogenous small in-
terfering RNA (exo-siRNA) pathway, which is induced by arbovirus-derived double-
stranded RNA in infected cells. Although recent work has shown the key role played
by Argonaute-2 (Ago-2) and Dicer-2 (Dcr-2) in this pathway, the regulatory mecha-
nisms that govern these pathways have not been studied in mosquitoes. Here, we
show that the Domino ortholog p400 has antiviral activity against the alphavirus
Semliki Forest virus (Togaviridae) both in Aedes aegypti-derived cells and in vivo. An-
tiviral activity of p400 was also demonstrated against chikungunya virus (Togaviri-
dae) and Bunyamwera virus (Peribunyaviridae) but not Zika virus (Flaviviridae). p400
was found to be expressed across mosquito tissues and regulated ago-2 but not
dcr-2 transcript levels in A. aegypti mosquitoes. These findings provide novel insights
into the regulation of an important aedine exo-siRNA pathway effector protein,
Ago-2, by the Domino ortholog p400. They add functional insights to previous ob-
servations of this protein’s antiviral and RNA interference regulatory activities in Dro-
sophila melanogaster.
IMPORTANCE Female Aedes aegypti mosquitoes are vectors of human-infecting
arthropod-borne viruses (arboviruses). In recent decades, the incidence of arthropod-
borne viral infections has grown dramatically. Vector competence is influenced by
many factors, including the mosquito’s antiviral defenses. The exogenous small inter-
fering RNA (siRNA) pathway is a major antiviral response restricting arboviruses in
mosquitoes. While the roles of the effectors of this pathway, Argonaute-2 and
Dicer-2 are well characterized, nothing is known about its regulation in mosqui-
toes. In this study, we demonstrate that A. aegypti p400, whose ortholog Domino
in Drosophila melanogaster is a chromatin-remodeling ATPase member of the
Tip60 complex, regulates siRNA pathway activity and controls ago-2 expression
levels. In addition, we found p400 to have antiviral activity against different ar-
boviruses. Therefore, our study provides new insights into the regulation of the
antiviral response in A. aegypti mosquitoes.
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Arthropod-borne viruses (arboviruses) are transmitted to susceptible mammalianhosts through the bite of infected arthropod vectors, such as mosquitoes. This
group of viruses includes those of medical and veterinary importance, such as chikun-
gunya virus (CHIKV) (Alphavirus; Togaviridae), dengue virus (DENV) (Flavivirus; Flaviviri-
dae), Zika virus (ZIKV) (Flavivirus; Flaviviridae), and Rift Valley fever virus (RVFV) (recently
reclassified into Phlebovirus; Phenuiviridae) (1–6). Given the medical and economic
impacts of arboviruses, viral interactions with mosquitoes and the impact on transmis-
sion remain important areas of research. New strategies to interfere with arbovirus
transmission involve genetically modified mosquitoes, including making mosquitoes
more resistant to arboviruses, as well as Wolbachia-endosymbiont-based approaches
(7–15). Arboviruses infect and replicate in both mammalian host and vector host cells;
as a consequence, they are detected by both mammalian and arthropod immune
systems. Compared to the wealth of knowledge on the mammalian antiviral immune
response, the arthropod response is not well characterized, yet it could provide
important targets for novel vector control measures. Research on this topic has
established that the key player in the antiviral immune response in mosquito vectors is
the exogenous small interfering RNA (exo-siRNA) pathway (8, 16–19). This pathway is
activated by the recognition of long viral double-stranded RNA (dsRNA) by the endo-
RNase Dicer-2 (Dcr-2). The effector protein Dcr-2 cleaves viral dsRNA into 21-nucleotide
(nt) virus-derived siRNAs (vsiRNAs), which are then loaded into the RNA-induced
silencing complex (RISC). One key protein within RISC, Argonaute-2 (Ago-2), binds the
siRNA and is believed to unwind the siRNA duplex and use one of the strands as a guide
to specifically recognize complementary RNAs, targeting these for degradation. In the
case of viral RNAs (such as genomes, antigenomes, or mRNAs), this results in an
inhibition of virus replication. The antiviral activity mediated by the exo-siRNA pathway
of vector mosquitoes has been demonstrated through the silencing or elimination/
absence of effector proteins (such as Ago-2 or Dcr-2), which results in an upregulation
of arbovirus replication. It has been shown to be active against arboviruses of all major
families or orders, alphaviruses (20–29), flaviviruses (30–34), and bunyaviruses (35–37).
Although the importance of the key exo-siRNA pathway components, such as Ago-2,
has been established, the regulation of this antiviral response, such as effector protein
expression, activity, and activation, remains poorly understood. Given its attractiveness
as a target for immunity-based control strategies in vectors, it is important that all of
the components, including regulatory mediators, of the exo-siRNA pathway are better
understood. In this study, we sought to identify new components of the antiviral
exo-siRNA pathway with the aim of understanding how the pathway functions and how
it is regulated. We show that the Aedes aegypti Domino ortholog p400 is expressed at
different levels across mosquito tissues and is an antiviral factor, since silencing of the
gene enhanced replication of the mosquito-borne alphavirus Semliki Forest virus (SFV).
We confirmed that p400 not only acts on SFV but also on the SFV-related alphavirus
CHIKV, as well as Bunyamwera virus (BUNV), a member of the Peribunyaviridae family.
However, p400 did not show antiviral activity against ZIKV. In addition, we have
identified p400 as a regulator of the exo-siRNA pathway activity, possibly by controlling
ago-2 but not dcr-2 transcript levels in vivo. Thus, our results hint that this protein may
exert antiviral activity through regulating the exo-siRNA pathway, although other
antiviral pathways potentially regulated by p400 cannot be excluded. These findings
help to further understand the regulation of the antiviral exo-siRNA pathway.
RESULTS
p400 is expressed in female mosquitoes. Previous studies have reported the role
of Domino in the antiviral response in Drosophila melanogaster (38). We therefore
wanted to determine if the A. aegypti Domino ortholog, p400, has a similar role
in mosquitoes. To determine if p400 was expressed in tissues relevant to arbovirus-
mosquito interactions, we first investigated the presence of p400 transcripts across
mosquito tissues. For this, individual tissues were dissected and hemocytes perfused
from non-blood-fed (NBF) female mosquitoes. RNA was extracted and transcript levels
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analyzed by reverse transcription-quantitative PCR (RT-qPCR). As shown in Fig. 1, p400
transcripts were detected in hemocytes and all tissues tested. The expression levels of
p400 varied across tissues, with low levels in salivary glands and high levels in ovaries.
The presence of p400 was also investigated by immunofluorescence. Consistent
with our RT-qPCR results, p400 was detected in hemocytes and several sampled tissues
(Fig. 2). p400 was expressed in all perfused hemocytes. It was restricted to the nucleus
in prohemocytes (Fig. 2A), which are small and spherical cells, with a high nuclear/
cytoplasmic ratio (39). It was expressed in the nucleus as well as in the cytoplasm of
differentiated hemocytes or granulocytes (Fig. 2B and C), which are bigger cells with
filopodia and a low nuclear/cytoplasmic ratio (39). In tissues, p400 was detected in the
nucleus of cells in the digestive tract, such as in the crop (Fig. 2E to H), in the ovarian
sheath surrounding the whole ovary and oviduct (Fig. 2J and M to P), and in the
ovariolar sheath surrounding each ovariole (Fig. 2K and L). In ovarioles, p400 was
expressed in some of the somatic cells forming the epithelium surrounding the
germarium and the primary previtellogenic follicle (Fig. 2K and L). In the germarium,
p400 was also strongly expressed in the nucleus of differentiating germ cells of the
developing cyst (which will give rise to the secondary follicle) as well as in the germ line
stem cells and to a lesser extent in the cystoblast germ cells (Fig. 2K). We also found
p400 in the tracheal cells surrounding various tissues (Fig. 2D and I to K).
p400 is antiviral against SFV in A. aegypti females. Yasunaga et al. previously
reported that Domino has antiviral activity against West Nile virus (WNV) and vesicular
stomatitis virus (VSV) in Drosophila DL1 cells (38). Therefore, we sought to determine if
the Domino ortholog p400 has similar antiviral activity in A. aegypti females. For this, we
assessed whether p400 could be silenced in vivo and determined the effect of this
knockdown on viral infection using the model alphavirus SFV. Female A. aegypti
mosquitoes were injected intrathoracically with p400-targeting dsRNA (dsp400) or
control lacZ-targeting dsRNA (dsLacZ). Mosquitoes were fed with a blood meal con-
taining SFV4 at 4 days post-dsRNA injection (pdi). At 3 days postinfection (pi), RNA was
extracted from whole females. Knockdown efficiency and virus genome levels were
determined by RT-qPCR. The knockdown of p400 transcript expression was confirmed
(Fig. 3A) and resulted in a significant increase in SFV RNA levels in whole females
(Fig. 3B), confirming the role of p400 in inhibiting SFV replication in A. aegypti female
mosquitoes. The results were repeated in a second independent experiment (see
Fig. S1 in the supplemental material).
p400 shows antiviral activity against SFV, CHIKV, and BUNV. To determine if the
antiviral action of p400 was specific to SFV or if it has broader antiviral activity, we
FIG 1 Detection of p400 transcripts in tissues of NBF A. aegypti females. Presence of p400 transcripts was
determined in hemocytes, salivary glands, digestive tracts, ovaries, and carcasses of NBF females by
RT-qPCR using the 2ΔΔCT method and expression in hemocytes as the reference sample. Bars represent
the fold change in gene expression from 3 independent biological replicates (pools of 25 digestive tracts
or ovaries, pools of 60 salivary glands, and pools of perfused hemocytes from 70 females per replicate).
Error bars show the minimum and maximum fold change.
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tested the effect of p400 knockdown on three other arboviruses belonging to different
families, the SFV-related alphavirus CHIKV, the bunyavirus BUNV, and the flavivirus ZIKV.
For this experiment, A. aegypti-derived Aag2 cells were used, and the effect of the p400
knockdown on SFV was used as a positive control. The reporter viruses used for these
experiments were CHIKV-2SG-FFLuc (FFLuc, firefly luciferase expressing), BUNV-NLuc
and ZIKV-NLuc (both NLuc, Nano luciferase expressing), and SFV4(3H)-FFLuc (also firefly
luciferase expressing) (25, 29, 35, 40). Aag2 cells were transfected with dsp400-targeting
or control dsRNA-targeting enhanced green fluorescent protein (dseGFP). Cells were
infected with CHIKV-2SG-FFLuc, BUNV-NLuc, ZIKV-NLuc, or SFV4(3H)-FFLuc at 24 h
posttransfection (pt). SFV- and CHIKV-infected cells were lysed 24 hpi, BUNV-infected
cells were lysed at 48 hpi, and ZIKV-infected cells were lysed at 72 hpi, and luciferase
activity was determined. The time posttransfection at which cells were collected was
chosen based on previous studies (29, 34, 35, 41). Knockdown of p400 (Fig. 4A) resulted
in a significant increase in SFV (Fig. 4B), confirming our results obtained in vivo, as well
as on CHIKV (Fig. 4C) and BUNV (Fig. 4D) replication. However, p400 knockdown had no
significant effect on ZIKV, possibly due to higher variation of luciferase expression
across replicates for this virus (Fig. 4E). To ensure that the absence of an effect on ZIKV
FIG 2 Detection of p400 protein in tissues of NBF A. aegypti females. Expression of p400 was analyzed
in perfused hemocytes (A to C), salivary glands (D), digestive tracts (E to I), and ovaries (J to P) by
immunofluorescence assay using an anti-p400 antibody. The signal was determined using an Alexa Fluor
568 goat anti-mouse IgG (HL) (red). Nuclei are stained by DAPI (blue signal), and F-actin is stained by
phalloidin 488 (green signal). Images were acquired on a Zeiss LSM 710 inverted confocal microscope
with 40, 63, and 100 oil immersion objectives. Scale bars are 5 m (A to C, F to H, and N to P) and
40 m (D, E, and I to M). (A) Perfused prohemocyte. (B and C) Perfused differentiated hemocytes. (D)
Salivary glands. (E) Crop. (F to H) Enlargement of panel E. (I) Midgut. (J) Oviduct. (K and L) Ovarioles
showing the germarium and primary follicle (pf). (M) Ovarioles surrounded by the ovarian sheath. (N to
P) Enlargement of panel M. Yellow star, developing cyst in the germarium; yellow arrowhead, germ line
stem cells. The cystoblast is located between the germ line stem cells and the developing cyst. Images
shown are representative of a minimum of 10 tissues per experiment from 3 independent experiments.
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was not due to the time of sampling, a time course of p400 knockdown and ZIKV
infection was performed with samples analyzed at 24, 48, and 72 hpi. p400 expression
was significantly reduced at all time points (Fig. S2A); however, luciferase expression
was not changed at any time point assessed (Fig. S2B).
p400 is required for exo-siRNA pathway activity and regulates levels of ago-2
in vivo. As p400 had previously been identified as being a component of the exo-siRNA
pathway in D. melanogaster-derived S2 cells (42), and we have shown here that it affects
arbovirus replication both in vitro and in vivo, we sought to determine if the antiviral
action of p400 could be due to an effect on the exo-siRNA pathway-silencing activity
in A. aegypti. In order to determine if p400 was important for exo-siRNA pathway
activity, reporter assays were performed. Aag2 cells were transfected with pIZ-FLuc
(expressing the silencing target FFLuc), pAcIE1-RLuc (as an internal transfection control,
expressing Renilla luciferase), and dsp400 or dseGFP (control). At 24 hpt, cells were
transfected again with dsRNA targeting either eGFP (control) or FFLuc (dsFFluc). Cells
were lysed 24 h after the second transfection, and luciferase activity was determined.
While the introduction of dsFFLuc in cells treated with dseGFP significantly decreased
FFLuc expression, silencing of the FFLuc reporter plasmid after the introduction of
dsFFLuc was abolished in the presence of p400-targeting dsRNA (Fig. 5), showing that
p400 is required for the activity of the exo-siRNA pathway.
Next, we aimed to identify what role p400 might play in the exo-siRNA pathway. In
human cells, p400 is part of the Tip60 complex and is involved in transcriptional
regulation through chromatin remodeling (43). We therefore reasoned that p400 may
play a regulatory role in the exo-siRNA pathway at the transcriptional level. In order to
test this hypothesis, we investigated the expression levels of the exo-siRNA effector
Ago-2 in SFV4-infected females following the knockdown of p400. The female mos-
quitoes injected with LacZ (control) or p400-targeting dsRNA and given a blood meal
containing SFV4 at 4 days pdi (used in Fig. 3B) were further analyzed for this purpose.
RT-qPCR was performed to assess transcript levels in whole females at 3 dpi. As shown
in Fig. 6A, ago-2 transcript expression levels in whole females were significantly
reduced upon p400 transcript knockdown in vivo. As described previously, the results
were repeated in a second independent experiment (Fig. S1). Similarly, ago-2 transcript
expression levels were also reduced in whole noninfected, NBF females following
knockdown of p400 transcripts (Fig. 6B). In contrast, knockdown of p400 had no
significant effect on dcr-2 transcript levels.
FIG 3 p400 knockdown significantly enhances replication of SFV in A. aegypti females. p400 and SFV
expression in whole dsLacZ- or dsp400-injected females 3 days after an SFV4-infected blood meal were
analyzed by RT-qPCR. Normalized expression-per-sample values were calculated as described by Taylor
et al. (78) in order to obtain normalized expression values, relative to the ribosomal S7 transcript as
reference, with a geomean of 1 for the dsLacZ control group. Bars represent the geomean and 95%
confidence intervals from n 73 dsLacZ and n 66 dsp400. The results were analyzed using a Mann-
Whitney test using log2-normalized expression values. This experiment is representative of two inde-
pendent biological replicates (second replicate shown in Fig. S1). (A) p400 transcript levels are signifi-
cantly reduced in dsp400-injected females compared to that in dsLacZ-injected females (mean fold
change, 1.7; geomean fold change, 1.6; ****, P  0.0001). (B) SFV4 titers are significantly higher in
dsp400-injected females than in dsLacZ-injected ones (mean fold change, 5.3; geomean fold change,
10.1; ****, P  0.0001). A base 10 log scale is used for the y axis.
p400 Is an Antiviral Factor in Aedes aegypti
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DISCUSSION
In this study, we found that p400, an ortholog of the TIP60 complex D. melanogaster
protein Domino, is antiviral against the arbovirus SFV in both A. aegypti mosquito-
derived cells in culture and adult females. We show that p400 is also antiviral against
the related alphavirus CHIKV as well as the bunyavirus BUNV. As already discussed,
antiviral activity against WNV (a mosquito-borne flavivirus; Flaviviridae) and VSV (Rh-
abdoviridae) has previously been attributed to the p400 ortholog Domino in D.
melanogaster-derived DL1 cells following a dsRNA screen for antiviral proteins (38). The
knockdown of other members of the Tip60 complex (RuvBL1, RuvBL2, and Tip60) in
mosquito cells was also shown to increase WNV and VSV replication (38), suggesting
that p400/Tip60 has broad and conserved antiviral activity in dipterans. In mammals,
FIG 4 p400 knockdown significantly enhances replication of SFV, CHIKV, and BUNV but not ZIKV. (A) p400
knockdown efficiency in Aag2 cells was analyzed by RT-qPCR using the 2ΔΔCT method and p400
expression calculated relative to eGFP dsRNA transfection. Bars show the fold change in gene expression
from 3 independent experiments (3 wells in each independent experiment, with an average of three
wells per condition/experiment used for statistical analysis). Error bars represent the minimum and
maximum fold change. The results were analyzed by a one-sample t test. p400 transcript levels are
significantly reduced after dsp400 transfection (P  0.039; *, P  0.05). The effect of p400 knockdown on
SFV-FFLuc (B), CHIKV-2SG-FFLuc (C), BUNV-NLuc (D), and ZIKV-NLuc (E) was assessed by a luciferase assay.
Bars show the means of the results from 3 independent experiments (3 wells in each independent
experiment, with the average of three replicates per condition/experiment used for statistical analysis).
Values were calculated relative to the control eGFP dsRNA-transfected sample, which was set to 1.
Statistical significance was determined by performing a one-sample t test (SFV P  0.0129, CHIKV P 
0.0286, and BUNV P  0.0257; *, P  0.05). Error bars show the standard error of mean.
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Tip60 has been reported to have antiviral activity against adenovirus (44). In contrast,
Tip60 can also promote infections with human papillomavirus (45, 46), human immu-
nodeficiency virus 1 (47, 48), and herpesviruses (46, 49). Therefore, the action of the
Tip60 complex, including p400, appears to have a positive or negative effect on virus
infection depending on the biological system and virus.
We further show that p400 is required for the activity of the exo-siRNA pathway. Our
results are consistent with a previous study in D. melanogaster-derived S2 cells in which
Domino was identified as a regulator of the siRNA pathway (42). As the exo-siRNA
FIG 5 p400 knockdown leads to reduced silencing efficiency. RNA silencing activity in the presence of
p400 knockdown was determined using a sensor assay. Aag2 cells were transfected with plasmids
constitutively expressing firefly (FFLuc) or Renilla luciferase and dsRNA targeting either p400 or eGFP as
a control. At 24 h post-initial transfection, dsRNA against FFLuc or eGFP was transfected. Silencing activity
was assessed by measuring the relative levels of FFLuc 24 h post-second transfection after normalization
to RLuc (internal transfection control) levels. The level of silencing was calculated relative to respective
control eGFP dsRNA-transfected samples (dseGFPdseGFP as a control for condition dseGFPdsFFLuc,
and dsp400dseGFP as a control for condition dsp400dsFFluc), which were set to 1. Bars show the
means from 3 independent experiments (3 wells in each independent experiment, average of three wells
per condition/experiment used for statistical analysis). Error bars show the standard error of mean.
Significance was determined by an unpaired t test to determine the P value (P  0.034; *, P  0.05).
FIG 6 Effect of p400 knockdown on ago-2 and dcr-2 transcript levels in A. aegypti females. (A) ago-2
transcript levels in whole dsLacZ- or dsp400-injected females 3 days after an SFV4-infected blood meal
was analyzed by RT-qPCR. Normalized expression-per-sample values were obtained as described by
Taylor et al. (78) in order to obtain normalized expression values, relative to the ribosomal S7 transcript
as a reference, with a geomean of 1 for the dsLacZ control group. Bars show the geomean and 95%
confidence intervals from n 73 dsLacZ and n 66 dsp400 females of a single experiment, also used in
Fig. 3. This experiment is representative of two independent experiments (second replicate shown in
Fig. S1). The results were analyzed using a Mann-Whitney test using log2-normalized expression values.
ago-2 transcript levels are significantly reduced in dsp400-injected females compared to those in
dsLacZ-injected ones (mean fold change, 1.2; geomean fold change, 1.1; P  0.0197; *, P  0.05). (B)
Transcript levels of p400, ago-2, and dcr-2 in whole non-blood-fed (NBF) females 4 days after injection
with dsLacZ or dsp400 were analyzed by RT-qPCR using the 2ΔΔCT method and expression in dsLacZ
females as the reference sample. Bars represent the fold change in gene expression (3 independent
biological replicates, with pools of 10 females per replicate). Error bars show the minimum and maximum
fold change. The results were analyzed using a one-sample t test. p400 and ago-2 transcript levels are
significantly reduced in dsp400-injected females compared to those in dsLacZ-injected females (70%
reduction, P  0.0047; and 42% reduction, P  0.0067; **, P  0.01).
p400 Is an Antiviral Factor in Aedes aegypti
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pathway limits SFV, BUNV, and CHIKV infection in mosquitoes (22, 23, 35), the action of
p400 against these viruses is likely to be mediated at least in part through this antiviral
pathway. In D. melanogaster, Domino is required for diptericin induction in the fat body
(50). Moreover, homozygous dom mutant D. melanogaster larvae do not contain
hemocytes and do not survive after pupariation, illustrating the important role that
Domino has in immunity (51). Roles of this protein also extend to cell proliferation/
growth and death (52, 53) and maintaining repression of proapoptotic genes (54). In
mammals, Tip60 has been reported to be antiviral by suppressing adenovirus gene
expression through binding to the immediate early promoter (44). Considering the
different roles of p400 previously described, we cannot therefore exclude that p400
could mediate antiviral effects in A. aegypti mosquitoes through other mechanisms in
addition to its role in the exo-siRNA pathway.
Consistent with our finding that p400 regulates ago-2 transcript levels, p400/
Domino is a chromatin-remodeling ATPase member of the Tip60 complex involved in
transcriptional regulation and chromatin modification in the fly model but also in
human cells (43, 55, 56). In human cells, Tip60/p400 complexes catalyze the incorpo-
ration of the histone variant H2A.Z within chromatin, including promoter regions to
modulate gene expression in response to diverse cellular cues (57). As Ago-2 is a main
effector in the exo-siRNA pathway, the action of p400 on this pathway activity is likely
to be mediated through the regulation of ago-2 expression. This could also be the
reason why Domino is required for the Ago-2-dependent RNA interference (RNAi)
activity in D. melanogaster-derived S2 cells (42). While p400 regulates ago-2 transcript
levels, p400 knockdown does not have any significant impact on the transcript levels
of another important exo-siRNA pathway component, dcr-2. Previous reports have
shown that Ago-2 is antiviral against SFV, BUNV, and CHIKV (22, 23, 35), while we and
others have shown that reduced or absent Ago-2 activity does not result in an increase
in ZIKV replication (34, 58, 59). Altogether, this could explain why p400 is antiviral
against SFV, BUNV, and CHIKV, while we could not detect any significant effect against
ZIKV. As previously discussed, p400 is an ATPase part of the Tip60 chromatin remod-
eling complex (43, 55, 56). Although the effect of p400 knockdown was not significant
on ZIKV, the slight increase in ZIKV expression may indicate that p400 could regulate
the expression of other antiviral genes in addition to ago-2. Outside antiviral responses,
p400 knockdown could even disturb virus replication in other ways, such as changes in
the expression of host factors.
We found that p400 was expressed across various tissues in non-blood-fed females,
with the strongest expression in ovaries. In the germarium, the protein is detected in
both the germ line and somatic cells, more predominantly in the germ line stem cells
and developing secondary follicle. In the primary previtellogenic follicle, p400 is slightly
expressed in some somatic epithelial cells. This is similar to the ovarian expression
pattern of the two alternative splicing isoforms, DomA and DomB, in D. melanogaster
adult females (60), with an expression in the developing cysts within the germarium
and little to no expression at stages 7 to 8 (corresponding to the primary follicle
arrested at the previtellogenic stage in mosquitoes). In the fruit fly, Domino is required
for oogenesis, more particularly for somatic and germ line stem cell maintenance as
well as cystocyte differentiation (56, 61, 62). In humans, there are two homologues of
Domino, p400 and SRCAP. Interestingly, SRCAP can rescue the female sterility of
hypomorphic dom alleles in D. melanogaster (63), showing functional conservation
of these SWR1-like remodelers during evolution. Due to the similar localization in
ovaries of Aedes and Drosophila spp., it is likely that p400 in mosquitoes and Domino
in flies exert similar functions during oogenesis. The protein p400 is also expressed in
the large nucleus of the ovarian sheath cells, as well as in the nucleus of the cells
forming the crop, suggesting a role in transcriptional regulation in these cells. We also
found p400 expressed in tracheae surrounding various tissues, including salivary
glands, digestive tract, and ovaries. Interestingly, the von Hippel-Lindau tumor sup-
pressor gene (VHL) regulates the expression of p400 posttranscriptionally in mouse
embryonic fibroblasts to prevent senescence (64). In D. melanogaster, VHL regulates
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tracheal branch migration and lumen formation through endocytosis (65). The pres-
ence of p400 in the mosquito tracheal system could indicate that it is involved in
tracheal morphogenesis. As arboviruses can infect tracheal cells in A. aegypti (66), p400
could also mediate antiviral protection in these cells. Consistent with its role in
hemocyte proliferation and differentiation in the fly model (51), p400 is expressed in
hemocytes in A. aegypti females, with the protein localized in the nucleus of undiffer-
entiated prohemocytes and in the nucleus and cytoplasm of differentiated hemocytes.
In D. melanogaster, hemocytes control viral infections by clearing virus-infected cells by
phagocytosis (67, 68) and by providing an Ago-2-dependent protection to naive cells
(69), resulting in higher viral loads in flies depleted of hemocytes. Consequently, p400
could indirectly control viral loads in A. aegypti due to a role in immune cell differen-
tiation. Hemocytes can be infected by viruses in vivo in mosquitoes (27, 70); therefore,
the antiviral action of p400 could be directly mediated through Ago-2, though we
cannot exclude other mechanisms. In the absence of genetic tools to drive p400
knockdown in a tissue-specific manner in mosquitoes, it is difficult to conclude with
certitude in vivo in which tissues/cells p400 is antiviral.
The exo-siRNA pathway is one of the key antiviral immune pathways in mosquitoes
(8, 16, 19). Despite the importance of this pathway in antiviral defense, there is a
considerable lack of understanding regarding how the pathway is regulated. Here, we
show a role of p400 in the regulation of ago-2 transcript levels (and subsequently, the
activity of the exo-siRNA pathway) and the antiviral response in A. aegypti. In addition
to extending the diverse functions of p400, it could explain the previous observations
of Domino’s antiviral activity in D. melanogaster cells and its role in regulating the
exo-siRNA pathway. Further studies will need to determine if and how exo-siRNA
pathway activity is differentially regulated across tissues in A. aegypti and whether this
is relevant for the transmission of arboviruses. In addition, more work will be necessary
to understand the mechanism by which p400 is antiviral. This could include interaction
studies with other cellular proteins, as well as promoter binding studies to assess
the wider mode of action of this protein, which might explain how ago-2 levels are
controlled by p400. The tools used in this study (primers, dsRNA, and antibody) target
the four p400 splicing isoforms predicted in A. aegypti genome annotation (AaegL5). As
there are two splicing isoforms, DomA and DomB, in D. melanogaster with distinct
functions during oogenesis (60), it would be interesting to identify which isoform is
involved in the exo-siRNA pathway regulation and antiviral activity in these species.
Future work on p400 in A. aegypti will have to investigate these key questions on its
mode of action and activity across tissues.
MATERIALS AND METHODS
Cell culture. A. aegypti-derived Aag2 cells (obtained from P. Eggleston, Keele University, UK) were
cultured in Leibowitz L-15 medium supplemented with 10% fetal bovine serum (FBS; Gibco), 10%
tryptose phosphate broth (TPB), and penicillin-streptomycin. Baby hamster kidney 21 (BHK-21) cells (a
commonly used cell line available at the MRC-University of Glasgow Centre for Virus Research) were
cultured in Glasgow minimum essential medium (GMEM), 10% newborn calf serum (NBCS) or FBS, 10%
TPB, and penicillin-streptomycin. A549 (human lung adenocarcinoma) NPro cells (a gift of R. E. Randall,
University of St. Andrews, UK) were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% FBS and penicillin-streptomycin, and the presence of bovine viral diarrhea virus
(BVDV)-derived NPro, which targets interferon regulatory factor 3 (IRF3) for degradation (71), was
maintained by the addition of blasticidin (10 g/ml). Aag2 cells were maintained at 28°C and BHK-21 and
A549 NPro cells at 37°C with 5% CO2.
Mosquito rearing. A. aegypti Liverpool strain (a gift from E. Devaney, University of Glasgow, UK) was
reared at 28°C and 80% humidity with a 12:12 light photoperiod. Larvae were reared in water and fed
on dry cat food from larvae hatching to the pupal stage. The emerging adult mosquitoes were removed
and put in cages with unlimited access to 10% (wt/vol) sucrose solution. For mass rearing, female
mosquitoes were fed on heparinized rabbit blood (Orygen Antibodies Ltd.) using a Hemotek system
(Hemotek Ltd., UK).
Reporter virus stocks, plaque assay titration, and infection. Luciferase expressing SFV4 contains
FFLuc inserted between nsP3 and nsP4 using duplicated nsP2 cleavage sites, as previously described (25,
72). pCMV-SFV4(3H)-FFLuc was electroporated into BHK-21 cells and incubated at 37°C until extensive cell
death was visible. The cell supernatant was harvested and clarified by centrifugation. The resulting virus
stock was stored at –80°C. CHIKV expressing FFLuc between the nonstructural and structural open
reading frames under a duplicated subgenomic promoter, CHIKV-2SG-FFLuc (25), was rescued by
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transfection of in vitro-transcribed RNA into BHK-21 cells. For this, pSP6-ICRES1-2SG-FFLuc was linearized
and in vitro transcribed using the SP6 MEGAscript kit (Thermo Fisher Scientific), along with Ribo m7G Cap
Analog (Promega), followed by transfection into BHK-21 cells using Lipofectamine 2000 (Thermo Fisher
Scientific), following the manufacturer’s instructions. The supernatant was collected, clarified by centrif-
ugation, and stored at –80°C. SFV4(3H)-FFLuc and CHIKV-2SG-FFLuc were titrated on BHK-21 cells by
making 10-fold serial dilutions and overlaying the inoculum with 0.6% Avicel in minimum essential
medium (MEM) containing 2% FBS and incubating at 37°C for 72 h. Cells were fixed using 10% formalin
(Sigma) and stained with 0.1% toluidine blue. NLuc-expressing BUNV was grown and titrated as
described previously (35). ZIKV-NLuc (40) was grown on A549 NPro cells cultured in DMEM supplemented
with 2% FBS and blasticidin (2 g/ml) for 5 days at 37°C with 5% CO2. Virus supernatant was collected
and cleared by centrifugation at 3,220  g for 10 min, followed by storage at –80°C. For virus titration,
cell monolayers of A549 NPro were infected with serially diluted ZIKV-NLuc in DMEM with 2% FBS and
incubated with an overlay consisting of MEM with 4% FBS, 4% HEPES, and 1.2% Avicel for 5 days. Infected
cells were fixed with 4% formaldehyde and stained with 0.2% bromophenol to visualize plaques. Aag2
cells were infected by removing the culture medium, overlaying with 200 l virus-containing inoculum,
and incubating at 28°C for 1 h. The inoculum was removed and replaced with complete medium,
followed by incubation at 28°C.
Aag2 cell infections were carried out with CHIKV-2SG-FFLuc at a multiplicity of infection (MOI) of 0.02,
with SFV4(3H)-FFLuc at an MOI of 0.1, with BUNV-NLuc at an MOI of 0.01, or with ZIKV-NLuc at an MOI
of 0.01 24 h posttransfection (hpt). SFV- and CHIKV-infected cells were lysed at 24 hpi, BUNV-infected
cells were lysed at 48 hpi, and ZIKV-infected cells were lysed at 72 hpi, and luciferase activity was
measured.
SFV production for oral infection of mosquitoes. SFV4 was produced from plasmid pCMV-SFV4, as
described previously (73). Briefly, the plasmid was transfected using Lipofectamine 2000 (Thermo Fisher
Scientific) into BHK-21 cells grown in GMEM with 2% FBS and 10% TPB at 37°C with 5% CO2. The virus
was titrated by a plaque assay on BHK-21 cells, as described above.
Plasmids. The pIZ-FLuc and pAcIE1-RLuc plasmids have been previously described (74, 75). The
plasmid pPUb-V5MBP was synthesized by subcloning maltose-binding protein (MBP) from pcDNA-
DEST40-MBP-hDVR (75) into the mosquito expression vector pPUb (29), based on an expression construct
containing the A. aegypti polyubiquitin promoter (76). The plasmid pUC57-p400 was synthesized
(GenScript) and contains the A. aegypti coding sequence, as indicated in VectorBase with accession
number AAEL001440 (assembly AaegL1). In the AaegL5 assembly, AAEL001440 was changed to
AAEL027494 (transcript identifiers [IDs] RA to RD; all transcripts targeted by dsp400). The p400 coding
sequence was further subcloned into the pPUb expression vector. The V5 tag was added to the N
terminus of pPUb-MBP and pPUb-p400 clones using the Infusion cloning technique (Clontech) to give
pPUb-V5MBP and pPUb-V5p400, respectively.
dsRNA synthesis for in vitro experiments. RNA was extracted from Aag2 cells using TRIzol (Thermo
Fisher Scientific), following the manufacturer’s guidelines. One microgram of RNA was reverse tran-
scribed using SuperScript III (Thermo Fisher Scientific) and an oligo(dT)15 primer (Promega), according
to the manufacturer’s instructions. Unique portions of candidate genes were amplified from cDNA with
primers containing T7 RNA polymerase minimal promoter sequence overhangs using GoTaq G2 Flexi
polymerase (Promega). PCR products were sequenced for target verification before the production of
dsRNA. For the production of dseGFP (used as a control), specific primers with T7 RNA polymerase
promoter sequences were used to amplify a unique portion of eGFP from a plasmid template containing
the eGFP-encoding gene. All primer sequences are listed in Table S1. The MEGAscript RNAi kit (Thermo
Fisher Scientific) was used to synthesize dsRNA from the PCR fragments, according to the manufacturer’s
guidelines.
dsRNA synthesis and purification for in vivo experiments. Total RNA was extracted with TRIzol
(Thermo Fisher Scientific) from whole NBF A. aegypti females, according to the manufacturer’s instruc-
tions, including DNase treatment (Turbo DNase; Ambion). cDNA was generated from 1 g of total RNA
using SuperScript III reverse transcriptase (Thermo Fisher Scientific) and oligo(dT)15. cDNAs were further
amplified with KOD Hot Start master mix (EMD Millipore). p400-specific primers (Table S1) with a T7 RNA
polymerase promoter sequence were used to amplify a p400-derived fragment (same primers used for
in vitro and in vivo experiments) and further purified using the QIAquick gel extraction kit (Qiagen). After
sequencing, the PCR product was used as the template for a second PCR using the same primers and
polymerase. For the production of dsLacZ (used as control dsRNA), specific primers with T7 RNA
polymerase promoter sequences were used to amplify a lacZ-derived fragment from plasmid template
Drosophila/act5C-Gal (stock number 1220 obtained from DGRC) containing the Escherichia coli lacZ
gene. dsRNAs were synthesized and purified using the MEGAscript RNAi kit (Thermo Fisher Scientific),
according to the manufacturer’s instructions. dsRNA was then purified and concentrated to 10 g/l in
nuclease-free water using sodium acetate (3 M; Ambion) and ethanol precipitation.
Transfection of BHK-21 cells. BHK-21 cells were plated at a density of 3 106 cells per well in 6-well
plates. One microgram of pPUb-V5MBP or pPUb-V5p400 was transfected the following day using
Dharmafect2 (Dharmacon), following the recommended protocol. Cells were collected 24 hpt by
trypsinization and plated in slides (ibidi) for immunostaining.
Transfection of mosquito cells. Aag2 cells were plated at a density of 1.7 105 cells per well in a
24-well plate. dsRNA or plasmid DNA was transfected the following day with Lipofectamine 2000
(Thermo Fisher Scientific), using the supplied protocol. The medium was replaced at 4 to 5 hpt.
Knockdown experiments were performed by transfecting 100 ng dsRNA into Aag2 cells. Plasmid sensor
assays were performed by transfecting 50 ng pIZ-FLuc and 8 ng pAcIE1-RLuc and 100 ng of either
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eGFP-targeting or p400-targeting dsRNA. At 24 h post-initial transfection, cells were transfected again
with 10 ng FFLuc- or eGFP-targeting dsRNA. The FFLuc and RLuc activities were measured at 24 h
post-second transfection.
Luciferase assay. Aag2 cells were lysed in 1 passive lysis buffer (Promega) and lysed by rocking at
room temperature for 20 min or stored in –20°C immediately. FFLuc and Renilla luciferase activities were
measured using the dual-luciferase assay system (or Steady-Glo luciferase assay system in the case of
CHIKV-2SG-FFLuc) (Promega); NLuc activities were measured by using the Nano-Glo luciferase assay
systems (Promega) (ZIKV-NLuc and BUNV-NLuc). All measurements were carried out on Glomax lumi-
nometers (Promega).
Total RNA extraction and RT-qPCR from cells. For analysis of p400 knockdown efficiency, cells were
lysed in TRIzol reagent (Thermo Fisher Scientific) at 24 hpt and extracted according to the manufacturer’s
instructions. Reverse transcription (RT) was performed using the SuperScript III enzyme kit (Thermo Fisher
Scientific) from 1 g of RNA in a final volume of 20 l. Quantitative PCR (qPCR) was carried out using Fast
SYBR green master mix (Applied Biosystems) on a 7500 Fast machine (Applied Biosystems). The primers
used are listed in Table S1. Data were analyzed with the 7500 Software v2.0.6, and transcript expression
relative to the ribosomal S7 as a reference was calculated according to the 2ΔΔCT method (77). The
dseGFP control was set to 1, and dsp400 samples were normalized to dseGFP. Data from 3 independent
biological replicates were analyzed using a one-sample t test (Prism software).
dsRNA injection into mosquitoes. At 1 to 2 days after emergence, cold-anesthetized female
mosquitoes were injected with dsRNA into their thorax using a nanoinjector (Nanoject II; Drummond
Scientific) with 2 g of dsRNA (dsp400 or dsLacZ) in 414 nl of injection solution. To increase knockdown
efficiencies, Cellfectin II transfection reagent (Thermo Fisher Scientific) was added to the injection
solution. Briefly, Cellfectin was mixed with Schneider’s Drosophila medium (1:1 [vol/vol]; Thermo Fisher
Scientific); this mix was added to dsRNA solution (1:1 [vol/vol]) previously adjusted with Schneider’s
medium to give 2 g of dsRNA per female/injection volume. The injection solution was then incubated
for 15 min at room temperature before injection.
Mosquito sampling, dissection, and hemocyte perfusion. To assess the effect of p400 knockdown
on ago-2 transcript levels in whole NBF females and in tissues, female mosquitoes injected with dsRNA
(targeting control or p400 transcripts) were sacrificed at 4 days pdi. Whole females (pools of 10 females)
and dissected tissues (pools of 25 digestive tracts or ovaries, pools of 60 salivary glands, and pools of
perfused hemocytes from 70 females) were further stored in tubes on dry ice before TRIzol was added
for RNA extraction. Digestive tracts include the posterior part of the esophagus, dorsal diverticula, crop,
midgut, Malpighian tubules, and hindgut. The tissues were carefully dissected from 5-day-old NBF
females in RNase-free 0.05% (vol/vol) phosphate-buffered saline with Tween 20 (PBS-T) and either placed
into tubes on dry ice before TRIzol was added for subsequent analysis of p400 and ago-2 tissue levels by
qPCR or added into 0.05% PBS-T on wet ice for fixation and immunostaining. Hemocytes were collected
by perfusion. Briefly, the last segment of the abdomen was cut, and mosquitoes were then injected in
the thorax with 0.01% PBS-T using a glass capillary mounted on a syringe. For RT-qPCR experiments,
PBS-T-diluted hemocytes were collected in tubes on ice and centrifuged at 375  g for 15 min at 4°C.
The supernatant was gently removed before adding TRIzol. For immunostaining, hemocytes were
perfused on slides (ibidi; 5 females per well, 4 wells per replicate). The slides were left for 30 min at 28°C
before removal of PBS-T and fixation.
Antibody production. The Peptide Supplied Polyclonal Antibody Package (mouse; catalog no.
SC1046) available from GenScript USA, Inc. was used to produce the p400 antibody. Peptide optimization
was performed using the OptimumAntigen design program provided by GenScript. The peptide GMN
KPKAIQDQNTSC (present in proteins AAEL027494-RA to AAEL027494-RD) was selected and conjugated
to keyhole limpet hemocyanin (KLH) for immunization into five BALB/c mice. Antiserum from mouse 5
was used in these experiments. The specificity of the antibody was confirmed by colocalization of p400
and V5 antibody signals in BHK-21 cells transfected with pPUb-V5p400 (Fig. S3). Further details on
antibody production are available upon request.
Immunofluorescence analysis of mosquito tissues, hemocytes, and BHK-21 cells. Salivary glands
and ovaries (minimum of n 10 each for 1 experiment for 3 independent experiments) were fixed at
room temperature (RT) for 20 min in 4% (w/vol) paraformaldehyde (PFA) diluted in 0.05% PBS-T. BHK-21
cells (2 independent experiments), perfused hemocytes, and digestive tract tissues (n 10 minimum for
1 experiment for 3 independent experiments) were fixed in the same way, except that PFA was diluted
using PBS. Fixed cells/tissues (except ovaries) were washed (three times for 15 min each at 4°C) in 0.05%
PBS-T before blocking for at least 30 min in blocking solution (0.05% PBS-T, 5% [vol/vol] fetal calf serum
[FCS], 5% [wt/vol] bovine serum albumin [BSA], 0.05% [vol/vol] Triton X-100) at 4°C. Unlike other tissues,
ovaries were dilacerated and washed in 1% PBS-T before being blocked in blocking solution containing
0.5% (vol/vol) Tween and 0.5% (vol/vol) Triton X-100. Cells/tissues were incubated at 4°C overnight with
a mouse anti-p400 antibody (see below) diluted 1:200 or a rabbit anti-V5 (Abcam) at 1:500 in blocking
solution. For each experiment, a negative control without primary antibody was carried out (Fig. S4).
Samples were washed (five times for 15 min each at 4°C) in 0.05% PBS-T (0.5% PBS-T for ovaries) and
incubated with an Alexa Fluor 568 goat anti-mouse IgG (HL) or an Alexa Fluor 488 goat anti-rabbit IgG
(HL) diluted 1:1,000, 1 4=,6-diamidino-2-phenylindole (DAPI) (405 nm), and 1 phalloidin (488 or
647 nm) in blocking solution for 2 h at RT. Four washes in 0.05% PBS-T (0.5% PBS-T for ovaries) were
carried out. Tissues were mounted between the slide and coverslip (24 mm by 24 mm) with an imaging
spacer (1 well, 13-mm diameter, 0.12-mm thickness, Grace Bio-Labs SecureSeal imaging spacer; Sigma-
Aldrich) using mounting medium (ibidi). Mounting medium was used to replace PBS-T in hemocyte- or
BHK-21-containing wells. Images were acquired on a Zeiss LSM 710 inverted confocal microscope,
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equipped with a 40, 63, or 100 oil immersion objective, and processed with Fiji/ImageJ and Adobe
Photoshop.
Blood meal infection of mosquitoes with SFV. At 4 days pdi, A. aegypti females were allowed to
feed for 30 min on blood meal containing SFV4. Fresh rabbit blood (Orygen Antibodies Ltd.) was washed
with PBS to remove white blood cells and serum. PBS was then added to the red blood cell fraction to
return to the initial blood volume. The infectious blood meal was prepared with 2/3 of washed blood and
1/3 of SFV-containing culture medium to give a final titer of 5.107 PFU/ml, supplemented with 2 mM ATP.
Only engorged females were kept further in the presence of 10% sucrose at 28°C and 80% humidity. At
3 days postfeeding, females were sampled individually before RNA extraction.
Total RNA extraction and RT-qPCR from mosquitoes. Dissected tissues or whole females were
homogenized in TRIzol reagent with glass beads using the Precellys 24 homogenizer (Bertin Instruments).
RNA from tissues, whole females, and hemocytes was extracted according to the manufacturer’s
instructions, except that 1-bromo-3-chloropropane was used instead of chloroform, and DNase (Turbo
DNase; Ambion) treatment was carried out. Reverse transcription (RT) was performed using the Moloney
murine leukemia virus (MMLV) retrotranscriptase (Promega) from 1 to 2 g of RNA in a final volume of
40 l. cDNA was aliquoted and further stored at –20°C until qPCR was carried out using Fast SYBR green
master mix (Applied Biosystems) on a 7500 Fast machine (Applied Biosystems). The primers used are
listed in Table S1. Data were analyzed with the 7500 Software v2.0.6.
For analysis of p400 expression, transcript expression relative to the ribosomal S7 transcript as a
reference was calculated according to the 2ΔΔCT method (77). The hemocyte sample was set to 1, and
other samples were normalized to the hemocyte sample. Data were obtained from 3 independent
biological replicates. For analysis of p400 knockdown efficiency and the effect on ago-2 levels in whole
NBF females, transcript expression relative to the ribosomal S7 transcript as a reference was calculated
according to the 2ΔΔCT method (77). The dsLacZ control was set to 1, and dsp400 samples were
normalized to dsLacZ. Data from 3 independent biological replicates (pool of 10 females per replicate)
were analyzed by a one-sample t test (Prism software). For analysis of p400 knockdown and the effect on
ago-2 levels and SFV infection, data were analyzed as described by Taylor et al. (78) in order to obtain
normalized expression values, relative to the ribosomal S7 transcript as a reference, with a geometric
mean (geomean) of 1 for the dsLacZ control group (two independent experiments; n 73 females for
dsLacZ and 66 for dsp400 in Fig. 3A and B and 6A; n 39 females for dsLacZ and 43 for dsp400 in Fig. S1).
Log2-normalized expression values were analyzed using a Mann-Whitney test (with the Prism software).
Data availability. The data sets generated and analyzed during the current study are available in the
University of Glasgow repository at https://doi.org/10.5525/gla.researchdata.705.
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